<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Males exhibit greater histologic and behavioral impairment after <z:hpo ids='HP_0001297'>stroke</z:hpo> than do age-matched females </plain></SENT>
<SENT sid="1" pm="."><plain>However, the contribution of <z:chebi fb="5" ids="50113">androgens</z:chebi> to <z:hpo ids='HP_0001297'>stroke</z:hpo> outcome remains unclear </plain></SENT>
<SENT sid="2" pm="."><plain>We compared outcomes from middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) in castrated mice with those in <z:chebi fb="51" ids="17347">testosterone</z:chebi>- or <z:chebi fb="1" ids="16330">dihydrotestosterone</z:chebi> (DHT)-replaced castrated mice </plain></SENT>
<SENT sid="3" pm="."><plain>Castrates treated with 1.5 mg <z:chebi fb="51" ids="17347">testosterone</z:chebi> or 0.5 mg DHT before MCAO showed smaller <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes (hemisphere: 27 or 26%) at 24 h after 90 mins MCAO than did untreated castrates (37%), whereas 5 mg <z:chebi fb="51" ids="17347">testosterone</z:chebi> or 1.5 mg DHT exacerbated <z:mpath ids='MPATH_124'>infarcts</z:mpath> (53 or 51%) </plain></SENT>
<SENT sid="4" pm="."><plain>These outcomes were blocked by the <z:chebi fb="3" ids="50113">androgen</z:chebi> receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, <z:chebi fb="0" ids="5132">flutamide</z:chebi>, suggesting that <z:chebi fb="3" ids="50113">androgen</z:chebi> receptors mediate these responses to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>We further evaluated long-term outcomes with a milder 60-min MCAO in castrates treated with the protective 1.5 mg <z:chebi fb="51" ids="17347">testosterone</z:chebi> dose </plain></SENT>
<SENT sid="6" pm="."><plain>Consistent with data obtained at 24 h reperfusion, the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume was decreased at 9 days reperfusion </plain></SENT>
<SENT sid="7" pm="."><plain>Neurobehavioral analysis showed that motor functional recovery was improved during the first 3 days of reperfusion, but not improved at 7 days </plain></SENT>
<SENT sid="8" pm="."><plain>We conclude that <z:chebi fb="51" ids="17347">testosterone</z:chebi> exhibits dose-dependent and time-sensitive effects after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and that <z:chebi fb="51" ids="17347">testosterone</z:chebi> is likely to be an important factor in sex-linked differences in cerebrovascular disease </plain></SENT>
</text></document>